Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.
Megan Van Etten

Megan Van Etten Megan Van Etten is senior director of public affairs at PhRMA. She is responsible for leading the association’s public affairs efforts on international issues, including trade, intellectual property and access to medicines. Prior to joining PhRMA, Megan was director of media and external communications at the U.S. Chamber of Commerce and communications director at the Beer Institute. She has also worked as a communications consultant for global public relations firms. When not at the office, Megan enjoys exploring new Washington, D.C. restaurants and traveling with her husband and friends.

Recent Posts

Setting the record straight on the Bayh-Dole Act and March-in

By Megan Van Etten  |    May 10, 2023
The National Institutes of Health (NIH) recently made the right decision to uphold the Bayh-Dole Act and not seize patent rights on an innovative medicine by exploiting part of the law known as the...   Read More

World IP Day 2023: Celebrating women leaders in innovation

By Megan Van Etten  |    April 26, 2023
Today PhRMA joins with innovators around the globe to recognize World IP Day and celebrate biopharmaceutical innovators who dedicate their lives to bringing new treatments and cures to patients. It’s...   Read More

What they are saying: Experts reinforce that TRIPS waiver expansion is harmful and unnecessary

By Megan Van Etten  |    April 13, 2023
At the direction of the U.S. Trade Representative, the U.S. International Trade Commission (USTIC) is investigating the impact of a proposed waiver of intellectual property (IP) protections for...   Read More

FDA-USPTO collaboration initiatives should be evidence-based, prioritize innovation

By Megan Van Etten  |    March 1, 2023
The United States Patent and Trademark Office (USPTO) and the U.S. Food and Drug Administration (FDA) are in the process of considering new collaboration initiatives aimed at biopharmaceutical...   Read More

PhRMA submits comments to USPTO highlighting important role of patent system in medicine development

By Megan Van Etten  |    February 23, 2023
PhRMA responded to the U.S. Patent and Trademark Office’s (USPTO) request for comments regarding USPTO initiatives to ensure the robustness and reliability of patent rights.   Read More

Expanding TRIPS waiver would jeopardize biopharmaceutical research and development

By Megan Van Etten  |    November 17, 2022
The United States has led the charge in the development of vaccines and treatments to combat COVID-19 thanks in large part to our robust innovation ecosystem, supported by intellectual property (IP)...   Read More

Six ways I-MAK is lying about biopharma patents

By Megan Van Etten  |    November 16, 2022
The Arnold-Venture funded advocacy group Initiative for Medicines, Access & Knowledge, Inc. (or I-MAK) is on a global media tour, espousing their point of view on the patent system. Some experts and...   Read More

TRIPS waiver expansion risks public health

By Megan Van Etten  |    November 14, 2022
The Biden administration and other World Trade Organization members are considering expanding the harmful and unnecessary waiver of intellectual property (IP) protections under the Agreement on...   Read More

Expanding the WTO intellectual property waiver will hurt American jobs

By Megan Van Etten  |    November 9, 2022
The June decision by WTO members to waive commitments to protect intellectual property (IP) for COVID-19 vaccines under the Trade-Related Aspects of Intellectual Property Rights (TRIPS) Agreement was...   Read More

The law driving technology transfer and fostering innovation

By Megan Van Etten  |    October 24, 2022
The bipartisan Bayh-Dole Act created a framework for researchers receiving federal funds to patent and license their inventions to companies for further development and commercialization. This...   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Contributor

View Posts by Date

see all

Subscribe to Email Updates